Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 95 peer-reviewed journal articles Updated
Neurology

Understanding Your IIH Diagnosis

At a Glance

Idiopathic Intracranial Hypertension (IIH) is a manageable condition caused by high fluid pressure in the skull, not a brain tumor. With prompt treatment and regular monitoring by a neurologist or neuro-ophthalmologist, you can safely control the pressure and protect your vision.

Hearing that you have a “fake brain tumor” (pseudotumor cerebri) is terrifying [1]. For many people, the path to this diagnosis is filled with intense, pounding headaches, strange whooshing sounds in the ears, and frightening changes in vision [1][2]. It is completely normal to feel overwhelmed and anxious when your body feels under pressure that no one else can see.

While the name “pseudotumor” was used for decades because the symptoms mimic a tumor, it is important to know right away: there is no tumor [1]. Instead, Idiopathic Intracranial Hypertension (IIH) is a condition where the fluid around your brain—cerebrospinal fluid (CSF)—is either being produced too quickly or not draining fast enough, creating high pressure inside your skull [1][3].

Three Facts to Steady You

When you are first diagnosed, it is easy to focus on the worst-case scenarios. Here are three stabilizing facts to help you find your footing:

  1. It is not a brain tumor. Although the pressure feels significant, there is no mass or growth [1][2].
  2. Vision loss is preventable. While IIH can put pressure on the optic nerves (the cables connecting your eyes to your brain), regular monitoring and treatment are highly effective at protecting your sight [2][4].
  3. It is a manageable condition. Most people with IIH live full, active lives [5]. With the right care team, the pressure can be controlled, and many patients even see their symptoms go into remission [6][7].

Why Your Doctor Might Seem Unfamiliar with IIH

You may notice that your primary care doctor or local ER physician seems hesitant or has to look up information about your condition. This is because IIH is rare, affecting at least 2.65 per 100,000 people in the general population [8]. Because the symptoms like headaches and blurry vision overlap with many common issues, non-specialists may not encounter it often enough to feel expert in its management [9][10].

If you need to go to the ER, it is highly recommended to bring a trusted companion to help you advocate for yourself, along with printed copies of your recent OCT scans or neurology notes. This is why seeing specialists like neuro-ophthalmologists (doctors who specialize in vision issues related to the nervous system) or neurologists is so important [2][11].

Who Gets IIH?

IIH most commonly affects women of childbearing age who are living with obesity [1][12]. However, it is vital to understand that IIH does not discriminate. It can and does occur in:

  • Men, who may actually be at a higher risk for rapid vision changes and need close monitoring [4].
  • Children, including those who are not overweight [13][14].
  • Thin individuals, for whom the cause may be related to different factors like medication reactions or anatomy [15][16].

What to Expect Moving Forward

The typical course of IIH involves a “marathon, not a sprint” approach. In the beginning, the focus is on lowering the pressure immediately to protect your vision, often using medications like acetazolamide [5][17].

You will likely have frequent eye exams that include Optical Coherence Tomography (OCT)—a non-invasive scan that measures the swelling of your optic nerves (papilledema) [18][19]. Over time, as treatment takes effect and lifestyle adjustments (like weight management where applicable) are made, the goal is to taper off medications while keeping your vision stable and your headaches under control [5][7].

Many newly diagnosed patients wonder about daily activities. Generally, flying on an airplane is safe, but activities that significantly increase pressure in your head—like lifting heavy weights or riding extreme rollercoasters—should be discussed with your doctor until your pressure is stabilized.

In this guide

6 chapters

01

Symptoms & Warning Signs of IIH

Learn the symptoms of Idiopathic Intracranial Hypertension (IIH). Understand pressure headaches, vision changes, pulsatile tinnitus, and when to get help.

02

The "Plumbing" of the Brain: Why IIH Happens

Learn what causes Idiopathic Intracranial Hypertension (IIH). Understand cerebrospinal fluid pressure, venous sinus stenosis, secondary causes, and MRI signs.

03

Understanding Your Diagnostics for IIH

Learn about the Idiopathic Intracranial Hypertension (IIH) diagnostic process. Understand your MRI, MRV, lumbar puncture results, and OCT eye exams.

04

Standard Treatment: Medical & Lifestyle Care

Learn about standard treatments for Idiopathic Intracranial Hypertension (IIH). Understand medications like Diamox, side effects, and weight loss strategies.

05

When Medicine Isn't Enough: Surgical Options for IIH

Learn about surgical options for Idiopathic Intracranial Hypertension (IIH) when medications aren't enough. Compare VSS, ONSF, and CSF shunting treatments.

06

Survivorship: Life After the Diagnosis

Learn what to expect after an IIH diagnosis. Understand long-term monitoring, managing persistent headaches, preventing recurrence, and navigating scan anxiety.

Common questions in this guide

Is idiopathic intracranial hypertension a type of brain tumor?
No, IIH is not a brain tumor. It is sometimes called "pseudotumor cerebri" because the high cerebrospinal fluid pressure causes symptoms like headaches and vision changes that mimic a tumor, but there is no actual mass or growth in the brain.
How does IIH affect my vision?
High fluid pressure in the skull can compress and swell the optic nerves, a condition known as papilledema. Without treatment, this can lead to vision loss, but regular monitoring and medication are highly effective at protecting your sight.
What does opening pressure mean in an IIH diagnosis?
Opening pressure is the measurement of cerebrospinal fluid pressure taken during a lumbar puncture, or spinal tap. This measurement helps your doctors confirm an IIH diagnosis and determine the best treatment plan to lower the pressure inside your skull.
What kind of doctors treat idiopathic intracranial hypertension?
Because IIH affects both the brain and the eyes, it is typically managed by a neurologist or a neuro-ophthalmologist. These specialists have the expertise required to monitor optic nerve swelling and safely manage cerebrospinal fluid pressure over time.
What is the main treatment for IIH?
The primary goal of treatment is to quickly lower the pressure in your head to protect your vision and relieve headaches. This is often achieved using medications like acetazolamide to reduce spinal fluid production, alongside long-term weight management when appropriate.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the 'opening pressure' measured during my lumbar puncture, and what does that mean for my specific treatment plan?
  2. 2.How often will we monitor my optic nerves using OCT (Optical Coherence Tomography) and visual field tests?
  3. 3.Are there any medications I am currently taking (like certain antibiotics or hormones) that could be contributing to my high pressure?
  4. 4.Do I have any signs of venous sinus stenosis, and would I benefit from seeing a neuro-interventionalist?
  5. 5.Since IIH is rare, how many patients with this condition do you typically manage in your practice?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Unilateral papilledema in idiopathic intracranial hypertension: A rare entity.

    Banerjee M, Aalok SP, Vibha D

    European journal of ophthalmology 2020; 1120672120969041 doi:10.1177/1120672120969041.

    PMID: 33143486
  2. 2

    Idiopathic Intracranial Hypertension in Children and Adolescents: An Update.

    Cleves-Bayon C

    Headache 2018; (58(3)):485-493 doi:10.1111/head.13236.

    PMID: 29194601
  3. 3

    Quantifying response to intracranial pressure normalization in idiopathic intracranial hypertension via dynamic neuroimaging.

    Lublinsky S, Kesler A, Friedman A, et al.

    Journal of magnetic resonance imaging : JMRI 2018; (47(4)):913-927 doi:10.1002/jmri.25857.

    PMID: 28960686
  4. 4

    A Man's Struggle With Idiopathic Intracranial Hypertension: A Unique Case Study.

    Al Jayyousi OA, Ba-Shammakh SA, Haj-Freej HM, et al.

    Cureus 2023; (15(8)):e43735 doi:10.7759/cureus.43735.

    PMID: 37727180
  5. 5

    Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management.

    Wang MTM, Bhatti MT, Danesh-Meyer HV

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (95()):172-179 doi:10.1016/j.jocn.2021.11.029.

    PMID: 34929642
  6. 6

    Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial.

    Mollan SP, Mitchell JL, Ottridge RS, et al.

    JAMA neurology 2021; (78(6)):678-686 doi:10.1001/jamaneurol.2021.0659.

    PMID: 33900360
  7. 7

    CT Cisternogram Findings in Idiopathic Cerebrospinal Fluid Leaks with Emphasis on Long Term Management.

    Velusamy A, Anand A, Hameed N

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2022; (74(Suppl 2)):1605-1611 doi:10.1007/s12070-021-02766-8.

    PMID: 36452803
  8. 8

    The incidence of idiopathic intracranial hypertension in Scotland: a SOSU study.

    Goudie C, Shah P, McKee J, et al.

    Eye (London, England) 2019; (33(10)):1570-1576 doi:10.1038/s41433-019-0450-y.

    PMID: 31040381
  9. 9

    Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report.

    Samara A, Ghazaleh D, Berry B, Ghannam M

    Journal of medical case reports 2019; (13(1)):94 doi:10.1186/s13256-019-2060-5.

    PMID: 30999940
  10. 10

    Headache, Loss of Smell, and Visual Disturbances: Symptoms of SARS-CoV-2 Infection? A Case Report.

    Maselli F, Storari L, Mourad F, et al.

    Physical therapy 2023; (103(4)) doi:10.1093/ptj/pzad017.

    PMID: 37116462
  11. 11

    Neurosurgical CSF Diversion in Idiopathic Intracranial Hypertension: A Narrative Review.

    Sunderland GJ, Jenkinson MD, Conroy EJ, et al.

    Life (Basel, Switzerland) 2021; (11(5)) doi:10.3390/life11050393.

    PMID: 33925996
  12. 12

    Update on Idiopathic Intracranial Hypertension.

    Wall M

    Neurologic clinics 2017; (35(1)):45-57 doi:10.1016/j.ncl.2016.08.004.

    PMID: 27886895
  13. 13

    Pediatric Idiopathic Intracranial Hypertension: Age, Gender, and Anthropometric Features at Diagnosis in a Large, Retrospective, Multisite Cohort.

    Sheldon CA, Paley GL, Xiao R, et al.

    Ophthalmology 2016; (123(11)):2424-2431 doi:10.1016/j.ophtha.2016.08.004.

    PMID: 27692528
  14. 14

    How do presentation age and CSF opening pressure level affect long-term prognosis of pseudotumor cerebri syndrome in children? Experience of a single tertiary clinic.

    Ozturk G, Turkdogan D, Unver O, et al.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2022; (38(1)):95-102 doi:10.1007/s00381-021-05365-8.

    PMID: 34568960
  15. 15

    Perioperative Diagnosis and Anaesthetic Management of Idiopathic Intracranial Hypertension in Pregnancy: A Case Report.

    Subedi P, Sharma M, Yogi P, Giri D

    JNMA; journal of the Nepal Medical Association 2023; (61(259)):263-266 doi:10.31729/jnma.8081.

    PMID: 37203943
  16. 16

    Increased Intracranial Pressure Due to Transverse Sinus Compression by a Meningioma En Plaque.

    Healy A, Singh U, Bhatia SS, et al.

    Cureus 2023; (15(1)):e33487 doi:10.7759/cureus.33487.

    PMID: 36756013
  17. 17

    Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis.

    Almaqhawi A, Alokley A, Alamri R, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(3)) doi:10.3390/medicina61030450.

    PMID: 40142261
  18. 18

    Peripapillary microperimetry for the diagnosis and follow-up of papilledema in cases treated for idiopathic intracranial hypertension.

    Elnahry GA, Elemary AM, Badr Eldin N, et al.

    Neurological research 2021; (43(1)):61-70 doi:10.1080/01616412.2020.1820811.

    PMID: 32915708
  19. 19

    Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension.

    Vijay V, Mollan SP, Mitchell JL, et al.

    JAMA ophthalmology 2020; (138(12)):1264-1271 doi:10.1001/jamaophthalmol.2020.4242.

    PMID: 33090189

This guide provides general educational information about an Idiopathic Intracranial Hypertension diagnosis. Always consult your neurologist or neuro-ophthalmologist for personalized medical advice, treatment plans, and symptom monitoring.

Get notified when new evidence is published on Idiopathic intracranial hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.